Essex Woodlands Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.39M | Hold |
|
|||||
|
2024
Q3 | $2.37M | Hold |
|
|||||
|
2024
Q2 | $1.17M | Hold |
|
|||||
|
2024
Q1 | $2.25M | Hold |
|
|||||
|
2023
Q4 | $4.02M | Hold |
|
|||||
|
2023
Q3 | $5.24M | Hold |
|
|||||
|
2023
Q2 | $11.6M | Hold |
|
|||||
|
2023
Q1 | $14.7M | Hold |
|
|||||
|
2022
Q4 | $8.44M | Hold |
|
|||||
|
2022
Q3 | $12.3M | Hold |
|
|||||
|
2022
Q2 | $6.32M | Hold |
|
|||||
|
2022
Q1 | $8.91M | Hold |
|
|||||
|
2021
Q4 | $7.46M | Sell |
|
|||||
|
2021
Q3 | $13.2M | Sell |
|
|||||
|
2021
Q2 | $37.3M | Sell |
|
|||||
|
2021
Q1 | $77.1M | Sell |
|
|||||
|
2020
Q4 | $94.7M | Hold |
|
|||||
|
2020
Q3 | $84M | Hold |
|
|||||
|
2020
Q2 | $81.6M | Hold |
|
|||||
|
2020
Q1 | $49.5M | Hold |
|
|||||
|
2019
Q4 | $54.2M | Hold |
|
|||||
|
2019
Q3 | $43.4M | Hold |
|
|||||
|
2019
Q2 | $43.3M | Hold |
|
|||||
|
2019
Q1 | $52.7M | Hold |
|
|||||
|
2018
Q4 | $91.7M | Hold |
|
|||||
|
2018
Q3 | $83M | Hold |
|
|||||
|
2018
Q2 | $91.7M | Sell |
|
|||||
|
2018
Q1 | $118M | Hold |
|
|||||
|
2017
Q4 | $137M | Sell |
|
|||||
|
2017
Q3 | $127M | Hold |
|
|||||
|
2017
Q2 | $121M | Hold |
|
|||||
|
2017
Q1 | $95.5M | Hold |
|
|||||
|
2016
Q4 | $95.1M | Hold |
|
|||||
|
2016
Q3 | $74.4M | Hold |
|
|||||
|
2016
Q2 | $62.5M | Hold |
|
|||||
|
2016
Q1 | $80.2M | Hold |
|
|||||
|
2015
Q4 | $157M | Hold |
|
|||||
|
2015
Q3 | $137M | Hold |
|
|||||
|
2015
Q2 | $147M | Hold |
|
|||||
|
2015
Q1 | $95.2M | Hold |
|
|||||
|
2014
Q4 | $77.8M | Hold |
|
|||||
|
2014
Q3 | $88.8M | Hold |
|
|||||
|
2014
Q2 | $156M | Hold |
|
|||||
|
2014
Q1 | $145M | Buy |
|